StockTipsArenaBeta

BUY Piramal Pharma Limited — Rachit Khandelwal

BUYPiramal Pharma Limited
Piramal Pharma share price target & all analyst calls

byRachit KhandelwalHorizon: 1–3 months26 Aug 2026via Business Today

Entry₹212.3Inferred
Target₹268
Total upside +26.24%
Stop lossNot given
CMP₹194.99Just now
Active-8.15%+37.44%upside left 5 wk left
Follow Rachit Khandelwal for new callsGet alertsWatch PPLPHARMA for new buy/sell callsGet alertsSee 1 other Short-term call on PPLPHARMASee 43 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 4:58 pm IST
21 supporting9 neutral5 opposing
Supports the BUY call (21)

RSI at 29 — oversold territory

Technicals · rsi·22 Oct · today

4 advisors have active long-term BUY calls on this stock

Advisor consensus · adjacent horizon·24 Sept · 4w ago

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·6 Aug · 3mo ago

Neutral / worth noting (9)

Q2 FY27 results scheduled — board meets 27 Oct 2026

BSE · Board Meeting·In 5 days

(opens in new tab)

These four pharma stocks will be reacting to important news updates today

NewsCnbc-Tv18·5 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (5)

MACD below its signal line — bearish momentum

Technicals · macd·22 Oct · today

Piramal Pharma received a GST order demanding Rs 4.06 crore in input tax credit plus an equivalent penalty of Rs 4.06 crore. The company plans to appeal the order and does not expect a material impact

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·29 Sept · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from Rachit Khandelwal

Every call and its outcome